REFERENCES
- Smith W, Assink J, Klein R, Mitchell P, Klaver C C, Klein B E, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001; 108: 697–704
- Seddon J M, Gensler G, Milton R C, Klein M L, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704–710
- Cumming R G, Mitchell P. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337: 8–14
- Klein R, Klein B E. Screening for diabetic retinopathy, revisited. Am J Ophthalmol 2002; 134: 261–263
- National Eye Institute. National Eye Institute (NEI) support for population-based studies, http://grants.nih.gov/grants/guide/notice-files/NOT-EY-06-004.html
- Chakravarti A, Little P. Nature, nurture and human disease. Nature 2003; 421: 412–414
- Manolio T A, Bailey-Wilson J E, Collins F S. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006; 7: 812–820
- Gorin M B, Breitner J C, de Jong P T, Hageman G S, Klaver C C, Kuehn M H, et al. The genetics of age-related macular degeneration. Mol Vis 1999; 5: 29
- Botto L D, Khoury M J. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 2001; 153: 1016–1020
- Khoury M J, Millikan R, Little J, Gwinn M. The emergence of epidemiology in the genomics age. Int J Epidemiol 2004; 33: 936–944
- Millikan R. The changing face of epidemiology in the genomics era. Epidemiology 2002; 13: 472–480